Global Clinical Trials

Pretoria 0157

0 studies enrolling now · 3 studies all time

What they study most

COVID-19, Chronic Spontaneous Urticaria, Coronavirus, Pneumonia, SARS (Disease), SARS-CoV-2 Acute Respiratory Disease, SARS-CoV-2 Infection

Studies at this site

• A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria — Running, not enrolling
• Safety and Immunogenicity of RNA-based Vaccines Against SARS-CoV-2 Variants in Healthy Participants — Completed
• A Study to Evaluate Efficacy and Safety of PTC299 (Emvododstat) in Hospitalized Participants With Coronavirus (COVID-19) — Stopped early